Skip to contentPucci Paolo — ARQULE INC insider: 124 transactions · InsiderLensPucci Paolo
- Chief Executive Officer at ARQULE INC · on record since Jun 11, 2008
- Director at ARQULE INC · on record since Aug 21, 2008
- Director at Replimune Group, Inc. · on record since Apr 7, 2026
- Director at DYAX CORP · on record since Nov 3, 2011
- Director at WEST PHARMACEUTICAL SERVICES INC · on record since May 6, 2026
- Director at NEWLINK GENETICS CORP · on record since Nov 16, 2015
- Former director at DYAX CORP · on record since Jan 22, 2016
- Chief Executive Officer at ARQULE INC · on record since Aug 28, 2017
- Director at Merus N.V. · on record since Jul 2, 2020
- Director at Trillium Therapeutics Inc. · on record since Jan 4, 2021
Insider trading activity of Pucci Paolo
- Transactions on record
- 124
- since Jun 11, 2008
- Open-market buys
- 23
- $313.6K
- Open-market sells
- 1
- $206.2K
- Companies traded
- 7
- last filing May 6, 2026
Figures computed from official regulatory filings — methodology.
Companies where Pucci Paolo has traded
Track record of Pucci Paolo
Statistical track record
Free- Open-market buys
- 23
- Last buy
- May 18, 2018
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of Pucci Paolo
Co-insiders of Pucci Paolo
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
ZENNER PATRICK JARQULE INC +1
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| May 6, 2026 | Award | 791 | 0.00 USD | $0 | SEC |
| Apr 7, 2026 | AwardD | 44,500 | 0.00 USD | $0 | SEC |
| Dec 12, 2025 | OtherD | -17,262 | 0.00 USD | $0 | SEC |
| Dec 12, 2025 | OtherD | -14,414 | 0.00 USD | $0 | SEC |
| Dec 12, 2025 | OtherD | -8,844 | 0.00 USD | $0 | SEC |
| Dec 12, 2025 | OtherD | -13,193 | 0.00 USD | $0 | SEC |
| Dec 12, 2025 | OtherD | -6,120 | 0.00 USD | $0 | SEC |
| Dec 12, 2025 | OtherD | -16,604 | 0.00 USD | $0 | SEC |
| May 27, 2025 | AwardD | 13,193 | 0.00 USD | $0 | SEC |
| May 8, 2025 | Award | 1,071 | 0.00 USD | $0 | SEC |
| Apr 3, 2025 | AwardD | 32,000 | 0.00 USD | $0 | SEC |
| May 9, 2024 | AwardD | 8,844 | 0.00 USD | $0 | SEC |
| Apr 25, 2024 | Award | 564 | 0.00 USD | $0 | SEC |
| Apr 3, 2024 | AwardD | 32,000 | 0.00 USD | $0 | SEC |
| Jun 12, 2023 | AwardD | 14,414 | 0.00 USD | $0 | SEC |
| Apr 27, 2023 | Award | 616 | — | — | SEC |
| Apr 4, 2023 | AwardD | 25,200 | 0.00 USD | $0 | SEC |
| Jun 2, 2022 | AwardD | 16,604 | 0.00 USD | $0 | SEC |
| May 26, 2022 | Award | 632 | — | — | SEC |
| Apr 5, 2022 | AwardD | 16,500 | 0.00 USD | $0 | SEC |
| Nov 19, 2021 | OtherD | -67,000 | 0.00 USD | $0 | SEC |
| Jun 2, 2021 | AwardD | 6,120 | 0.00 USD | $0 | SEC |
| May 6, 2021 | Award | 577 | — | — | SEC |
| Apr 5, 2021 | AwardD | 16,500 | 0.00 USD | $0 | SEC |
| Jul 2, 2020 | AwardD | 17,262 | 0.00 USD | $0 | SEC |